Tuberculosis Trial, Recruiting NCT06593080 Sponsor: Chishala Chabala Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06593080
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children under 15 years old who are sick and visiting selected health facilities, whether for an outpatient appointment or staying in hospital
  • Children who belong to higher-risk groups, including those under 2 years old, children living with HIV, or children who are severely malnourished
  • Children who have been identified as having been in close contact with someone who has TB, found either through community outreach or at a health facility
  • Children who show possible signs of TB, meaning they have had any one of these symptoms for more than 2 weeks without improvement: cough, fever, poor appetite, weight loss or poor growth, tiredness, reduced playfulness, or lower activity levels
  • Children with severe malnutrition (SAM) are identified using standard measurements such as weight compared to height, arm circumference, or visible swelling in both legs (confirm with trial site for exact measurements used locally)

Who may not be able to join:

  • There are no exclusion criteria for this trial — all eligible children will be offered the intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olivier Marcy, University of Bordeaux

Phone: +330557574723

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chishala Chabala
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
31 August 2027

Where this trial is recruiting

Zambia

Primary endpoints

Effectiveness endpoints: Children initiated on TB treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov